Market Place
Sourcing Support
Immetas Announces Series A Financing for Cancer and Inflammatory Disease
23 Sep 2020 //
BUSINESSWIRE
Tesaro`s injected chemo nausea med Varubi can cause anaphylaxis, company warns
16 Jan 2018 //
FIERCE PHARMA
TESARO Announces U.S. FDA Approval of VARUBI® IV for Delayed Nausea & Vomiting
25 Oct 2017 //
GLOBENEWSWIRE
Tesaro Uk Varuby (Rolapitant) Receives Approval In Europe
31 May 2017 //
EMA
Tesaro`s Varuby (Rolapitant) Receives Approval In Europe
31 May 2017 //
EMA
Six new medicines endorsed for EU approval
27 Feb 2017 //
PHARMATIMES
J&J gets CHMP backing for broader Darzalex use
27 Feb 2017 //
PMLIVE
Sanofi awaits FDA inspection of fill/finish plant before Q1 Kevzara resubmission
10 Feb 2017 //
IN PHARMATECHNOLOGIST
3 Potential Acquisition Targets for Gilead Sciences, Inc.
16 Nov 2016 //
THE MOTLEY FOOL
Tesaro`s Varubi (Rolapitant) Approved in US For Nausea and Vomiting
03 Sep 2015 //
FDA
Tesaro licenses PDUFA-status candidate rolapitant to China`s Jiangsu Hengrui
03 Aug 2015 //
FIERCE PHARMA ASIA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.